3.8 Article

Nanoparticle-mediated hyperthermia in cancer therapy

Journal

THERAPEUTIC DELIVERY
Volume 2, Issue 8, Pages 1001-1014

Publisher

FUTURE SCI LTD
DOI: 10.4155/TDE.11.72

Keywords

-

Funding

  1. NCI NIH HHS [R21 CA133691-01A2, R01 CA155446, R01 CA132032-04S1, R01 CA132032, R21 CA133691-02, U01 CA151886, R01 CA155446-02, R01 CA132032-05, R21 CA133691, R01 CA155446-01A1] Funding Source: Medline
  2. NCRR NIH HHS [KL2 RR024149-05, KL2 RR024149, KL2 RR02414905] Funding Source: Medline

Ask authors/readers for more resources

A small rise in tumor temperature (hyperthermia) makes cancer cells more susceptible to radiation and chemotherapy. The means of achieving this is not trivial, and traditional methods have certain drawbacks. Loading tumors with systematically asministered energy-transducing nanoparticles can circumvent several of the obstacles to achieve tumor hyperthermia. However, nanoparticles also face unique challenges prior to clinical implementation. This article summarizes the state-of-the-art current technology and discusses the advantages and challenges of the three major nanoparticle formulations in focus: gold nanoshells and nanorods, superparamagnetic iron oxide particles and carbon nanotubes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available